Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to browse AJSM online!

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Unic, I.
Right arrow Articles by Van Daal, W. A.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Unic, I.
Right arrow Articles by Van Daal, W. A.J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Assessment of the Time-tradeoff Val ues for Prophylactic Mastectomy of Women with a Suspected Genetic Predisposition to Breast Cancer

Ivana Unic

Peep F.M. Stalmeier

Lia C.G. Verhoef

Willem A.J. Van Daal

Background. Female carriers of the breast-cancer-susceptibility genes BRCA1 and BRCA2 are at high risk for breast cancer (85%). They face the choice between pro phylactic mastectomy (PM) and breast cancer screening. For this treatment choice, a shared-decision-making program was developed. In this program, the time tradeoff (TTO) was used to assess preferences for PM. Purpose. Assessment of the feasibility, constant proportional tradeoff, and reliability of using the TTO for this purpose. Meth ods. Fifty-four women suspected to carry the BRCA1/2 mutation were provided with comprehensive relevant information. Their preferences for PM were assessed on two occasions. Discrepancies between preferences indicated by the two tests were re solved by testing a third time. The preferences assessed on the last occasion were used for individual decision analyses. In order to test constant proportional tradeoff, the TTO consisted of four items with different numbers of life years. Results. Forty- two women (78%) completed the TTO twice and nine women (17%) performed the test a third time. Three women (5%) completed the TTO only once. The mean TTO value for PM at the last replication was 0.69 (SD = 0.30). Violations of constant pro portional tradeoff were significant: the largest tradeoffs were recorded for the shortest durations. Pearson's correlation coefficient between the TTO values for the two last sessions was 0.96. Conclusion. Assessment of individual preferences by the TTO in this patient group is feasible and reliable. Therefore, the TTO can be used in clinical settings to elicit treatment preferences of women proven or suspected to have a ge netic predisposition to breast cancer. Key words: shared decision making; breast can cer ; prophylactic mastectomy; preference assessment; time tradeoff; genetic predis position. (Med Decis Making 1998;18:268-277)

Medical Decision Making, Vol. 18, No. 3, 268-277 (1998)
DOI: 10.1177/0272989X9801800303


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Med Decis MakingHome page
A. Tsuchiya and P. Dolan
The QALY Model and Individual Preferences for Health States and Health Profiles over Time: A Systematic Review of the Literature
Med Decis Making, July 1, 2005; 25(4): 460 - 467.
[Abstract] [PDF]


Home page
Med Decis MakingHome page
M. Locadia, P. F. M. Stalmeier, F. J. Oort, M. H. Prins, M. A. G. Sprangers, and P. M. M. Bossuyt
A Comparison of 3 Valuation Methods for Temporary Health States in Patients Treated with Oral Anticoagulants
Med Decis Making, November 1, 2004; 24(6): 625 - 633.
[Abstract] [PDF]


Home page
JCOHome page
M.S. van Roosmalen, P.F.M. Stalmeier, L.C.G. Verhoef, J.E.H.M. Hoekstra-Weebers, J.C. Oosterwijk, N. Hoogerbrugge, U. Moog, and W.A.J. van Daal
Randomized Trial of a Shared Decision-Making Intervention Consisting of Trade-Offs and Individualized Treatment Information for BRCA1/2 Mutation Carriers
J. Clin. Oncol., August 15, 2004; 22(16): 3293 - 3301.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
P. F. M. Stalmeier
Discrepancies between Chained and Classic Utilities Induced by Anchoring with Occasional Adjustments
Med Decis Making, February 1, 2002; 22(1): 53 - 64.
[Abstract] [PDF]


Home page
Med Decis MakingHome page
W. Sumner II and R. F. Nease Jr.
Choice-Matching Preference Reversals in Health Outcome Assessments
Med Decis Making, May 1, 2001; 21(3): 208 - 218.
[Abstract] [PDF]


Home page
Med Decis MakingHome page
I. Unic, L. C.G. Verhoef, P. F.M. Stalmeier, and W. A.J. Van Daal
Prophylactic Mastectomy or Screening in Women Suspected to Have the BRCA1/2 Mutation: A Prospective Pilot Study of Women's Treatment Choices and Medical and Decision-analytic Recommendations
Med Decis Making, July 1, 2000; 20(3): 251 - 262.
[Abstract] [PDF]


Home page
Med Decis MakingHome page
P. F.M. Stalmeier, I. J. Unic, L. C.G. Verhoef, and W. A.J. Van Daal
Evaluation of a Shared Decision Making Program for Women Suspected to Have a Genetic Predisposition to Breast Cancer: Preliminary Results
Med Decis Making, August 1, 1999; 19(3): 230 - 241.
[Abstract] [PDF]